Zurich Insurance Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.7M | Sell |
406,602
-32,636
| -7% | -$1.9M | 0.19% | 135 |
|
|
2025
Q4 | $23.7M | Sell |
439,238
-2,395
| -0.5% | -$115K | 0.16% | 141 |
|
|
2025
Q3 | $19.9M | Buy |
+441,633
| New | +$20.6M | 0.14% | 120 |
|
|
2025
Q2 | – | Sell |
-428,668
| Closed | -$26.1M | – | 264 |
|
|
2025
Q1 | $26.1M | Sell |
428,668
-53,936
| -11% | -$3.14M | 0.21% | 108 |
|
|
2024
Q4 | $27.3M | Buy |
482,604
+422,804
| +707% | +$23.6M | 0.22% | 110 |
|
|
2024
Q3 | $3.09M | Hold |
59,800
| – | – | 0.03% | 136 |
|
|
2024
Q2 | $2.48M | Hold |
59,800
| – | – | 0.02% | 142 |
|
|
2024
Q1 | $3.24M | Hold |
59,800
| – | – | 0.03% | 145 |
|
|
2023
Q4 | $3.07M | Hold |
59,800
| – | – | 0.03% | 146 |
|
|
2023
Q3 | $3.47M | Hold |
59,800
| – | – | 0.04% | 140 |
|
|
2023
Q2 | $3.82M | Hold |
59,800
| – | – | 0.04% | 124 |
|
|
2023
Q1 | $4.14M | Hold |
59,800
| – | – | 0.05% | 125 |
|
|
2022
Q4 | $4.3M | Hold |
59,800
| – | – | 0.06% | 108 |
|
|
2022
Q3 | $4.25M | Sell |
59,800
-526,584
| -90% | -$38.2M | 0.07% | 105 |
|
|
2022
Q2 | $45.2M | Buy |
586,384
+526,584
| +881% | +$40.1M | 0.67% | 47 |
|
|
2022
Q1 | $4.37M | Hold |
59,800
| – | – | 0.05% | 110 |
|
|
2021
Q4 | $3.73M | Buy |
59,800
+29,300
| +96% | +$1.72M | 0.04% | 98 |
|
|
2021
Q3 | $1.8M | Hold |
30,500
| – | – | 0.02% | 135 |
|
|
2021
Q2 | $2.04M | Buy |
+30,500
| New | +$1.99M | 0.03% | 128 |
|
|
2020
Q1 | – | Sell |
-417,103
| Closed | -$26.8M | – | 208 |
|
|
2019
Q4 | $26.8M | Buy |
417,103
+130,837
| +46% | +$7.49M | 0.48% | 65 |
|
|
2019
Q3 | $14.5M | Buy |
286,266
+26,035
| +10% | +$1.22M | 0.28% | 92 |
|
|
2019
Q2 | $11.8M | Sell |
260,231
-82,129
| -24% | -$3.83M | 0.23% | 119 |
|
|
2019
Q1 | $16.3M | Buy |
342,360
+76,619
| +29% | +$3.82M | 0.35% | 78 |
|
|
2018
Q4 | $13.8M | Buy |
265,741
+5,996
| +2% | +$322K | 0.33% | 91 |
|
|
2018
Q3 | $16.1M | Sell |
259,745
-275
| -0.1% | -$16.3K | 0.34% | 82 |
|
|
2018
Q2 | $14.4M | Sell |
260,020
-38,677
| -13% | -$2.09M | 0.33% | 80 |
|
|
2018
Q1 | $18.9M | Buy |
298,697
+28,867
| +11% | +$1.86M | 0.44% | 51 |
|
|
2017
Q4 | $16.5M | Buy |
269,830
+42,262
| +19% | +$2.64M | 0.39% | 53 |
|
|
2017
Q3 | $14.5M | Buy |
227,568
+307
| +0.1% | +$17.9K | 0.4% | 55 |
|
|
2017
Q2 | $12.7M | Sell |
227,261
-27,299
| -11% | -$1.49M | 0.36% | 58 |
|
|
2017
Q1 | $13.8M | Sell |
254,560
-71,396
| -22% | -$3.92M | 0.4% | 56 |
|
|
2016
Q4 | $19M | Buy |
325,956
+97,990
| +43% | +$5.36M | 0.6% | 37 |
|
|
2016
Q3 | $12.3M | Sell |
227,966
-82,759
| -27% | -$5.32M | 0.41% | 57 |
|
|
2016
Q2 | $22.9M | Buy |
310,725
+8,959
| +3% | +$633K | 0.8% | 29 |
|
|
2016
Q1 | $19.3M | Sell |
301,766
-145,375
| -33% | -$9.17M | 0.69% | 39 |
|
|
2015
Q4 | $30.8M | Buy |
447,141
+142,573
| +47% | +$9.42M | 1.1% | 20 |
|
|
2015
Q3 | $18M | Buy |
+304,568
| New | +$19.3M | 0.66% | 58 |
|
Other funds holding BMY
VCM
VPM
Zurich Insurance Group's BMY Position: Q1 2026 in Review
Zurich Insurance Group reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q1 2026, selling an estimated $1.9M and leaving 406,602 shares worth $24.7M. The position accounts for 0.19% of the portfolio, ranked #135.
Zurich Insurance Group first reported a position in BMY in Q3 2015 and has held it in 37 quarters since. The position peaked at $45.2M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Zurich Insurance Group held 406,602 shares of Bristol-Myers Squibb worth $24.7M as of Q1 2026.
- Zurich Insurance Group sold 32,636 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.9M.
- Bristol-Myers Squibb made up 0.19% of Zurich Insurance Group's portfolio in Q1 2026, its #135 holding.
- Zurich Insurance Group first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 37 quarters since.
- Zurich Insurance Group's Bristol-Myers Squibb position peaked at $45.2M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.